Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - metformin hydrochloride,rosiglitazone maleate -

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - metformin hydrochloride -

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

pinewood healthcare - metformin hydrochloride - oral solution - 100mg/1ml

Malta - angļu - Malta Medicines Authority

alfred e. tiefembacher (gmbh &co. kg) - vildagliptin; metformin hydrochloride - film-coated tablet - vildagliptin 50 mg; metformin hydrochloride 850 mg - drugs used in diabetes

Malta - angļu - Malta Medicines Authority

alfred e. tiefembacher (gmbh &co. kg) - vildagliptin; metformin hydrochloride - film-coated tablet - vildagliptin 50 mg; metformin hydrochloride 1000 mg - drugs used in diabetes

Kanāda - angļu - Health Canada

apotex inc - dapagliflozin; metformin hydrochloride - tablet - 5mg; 850mg - dapagliflozin 5mg; metformin hydrochloride 850mg

Kanāda - angļu - Health Canada

apotex inc - dapagliflozin; metformin hydrochloride - tablet - 5mg; 1000mg - dapagliflozin 5mg; metformin hydrochloride 1000mg

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - metformin hydrochloride 1000mg;  ;  ; vildagliptin 50mg;  ;  ;   - film coated tablet - 50mg/1000mg - active: metformin hydrochloride 1000mg     vildagliptin 50mg       excipient: hyprolose hypromellose iron oxide yellow macrogol 4000 magnesium stearate purified talc titanium dioxide - for patients with type 2 diabetes mellitus (t2dm). galvumet is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes mellitus whose diabetes is not adequately controlled on metformin hydrochloride or vildagliptin alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. galvumet is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea. galvumet is indicated as add-on to insulin as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - metformin hydrochloride 850mg;  ;  ; vildagliptin 50mg;  ;  ;   - film coated tablet - 50mg/850mg - active: metformin hydrochloride 850mg     vildagliptin 50mg       excipient: hyprolose hypromellose iron oxide yellow macrogol 4000 magnesium stearate purified talc titanium dioxide - for patients with type 2 diabetes mellitus (t2dm). galvumet is indicated as an adjunct to diet and exercise to improve glycaemic control in patients with type 2 diabetes mellitus whose diabetes is not adequately controlled on metformin hydrochloride or vildagliptin alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. galvumet is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea. galvumet is indicated as add-on to insulin as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Malta - angļu - Malta Medicines Authority

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - film-coated tablet - metformin hydrochloride 1000 mg vildagliptin 50 mg - drugs used in diabetes